Ncardia
Suzanne Snellenberg has vast experience in various roles within the biotechnology industry, with a strong background in genome engineering and cell line development. Suzanne has held positions at Cellistic as VP Cell Line Development and Director Genome Engineering, as well as at Ncardia as Director Genome Engineering. Prior to these roles, Suzanne worked at OXGENE where Suzanne held positions such as Head of Discovery Services and Senior Scientist in Gene Editing. Their academic background includes a PhD from VU University Medical Center and a MSc in Biomolecular Sciences from Vrije Universiteit Amsterdam.
This person is not in the org chart
Ncardia
Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications. Explore our website to learn more www.ncardia.com.